Global Innovation Layout
Suzhou Siyao has established 14 research and development centers in the United States, Europe, Australia, Japan, and China, building a global research and development system with complementary strengths and functions.
Innovative talents
After years of development, the company has formed a large-scale, professional, and comprehensive R&D team of over 5000 people, which has formed a certain competitive advantage in innovation and execution capabilities in multiple disease research and development fields, providing strong talent support for the company's high-quality development.
Innovation Technology Platform
The company has established a number of new technology platforms with independent intellectual property rights and international expertise, such as protein hydrolysis targeted chimeras (PROTAC), molecular gels, antibody conjugated drugs (ADC), bispecific/multispecific antibodies, AI molecular design, drug resistance, in vivo pharmacology, molecular dynamics, biological information, etc., providing a strong foundation for innovative research and development.
Suzhou N0.4 Medicines
Adhere to the development strategy of putting technological innovation first
Continuously strengthening the research and development system and capacity building
Understand the stories of other four medicines
Return R&D Innovation
Contact
Quick Contact
Scanning Code
WeCom
Wechat official account
The Little Red Book
WeCom
WeChat official account
The Little Red Book
Contact
Quick Contact
© Copyright 2024 Suzhou No.4 Pharmaceutical Factory Co., Ltd 苏ICP备2022015841号-1 技术支持：苏州网站建设
© Copyright 2024 Suzhou No.4 Pharmaceutical Factory Co., Ltd
苏ICP备2022015841号-1 技术支持：苏州网站建设
